Patent · US Active

Anti-HSA antibodies

US11365240B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Numab Therapeutics AG · CH

Inventors

Tea Gunde · Zürich, CH
Sebastian Meyer · Bielefeld, DE
Christian Hess · Zürich, CH
Tessa Bieri · Morges, CH

Key dates

Filing date	Jun 4, 2018
Grant date	Jun 21, 2022
Priority date	—
Expiry date	Jun 4, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to novel antibodies that are specific for human serum albumin (HSA).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.